Request Deal Involvement

Foresite Capital and TCGX led a $105m financing round in CG Oncology.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

KKH Advisors

pr advisors

KKH Advisors

Latham & Watkins

legal advisors

Latham & Watkins

or

Principals

AVIDITY PARTNERS

bidder

AVIDITY PARTNERS

ACORN BIOVENTURES

bidder

ACORN BIOVENTURES

ALLY BRIDGE GROUP

bidder

ALLY BRIDGE GROUP

DECHENG CAPITAL LLC

bidder

DECHENG CAPITAL LLC

LONGITUDE CAPITAL MANAGEMENT CO LLC

bidder

LONGITUDE CAPITAL MANAGEMENT CO LLC

CG ONCOLOGY

target

CG ONCOLOGY

FORESITE CAPITAL MANAGEMENT LLC

bidder

FORESITE CAPITAL MANAGEMENT LLC

MALIN CORPORATION PLC

bidder

MALIN CORPORATION PLC

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

TCGX

bidder

TCGX

BVF PARTNERS

bidder

BVF PARTNERS

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Foresite Capital and TCGX led a $105m financing round in CG Oncology.